[1]AngewandteChemie-InternationalEdition,2012,vol.51,p.11606-11610 Angew.Chem.,2012,vol.124,p.11774-11778,5
[1]EuropeanJournalofMedicinalChemistry,2013,vol.67,p.75-80
[1]EuropeanJournalofMedicinalChemistry,2013,vol.67,p.75-80
[1]Patent:US2013/323169,2013,A1.Locationinpatent:Paragraph0309;0310
[1]ChemMedChem,2011,vol.6,p.54-59
Title: Native intact mass determination of antibodies conjugated with monomethyl Auristatin E and F at interchain cysteine residues.
Journal: Analytical chemistry 20120320
Title: Targeting cell surface alpha(v)beta(3) integrin increases therapeutic efficacies of a legumain protease-activated auristatin prodrug.
Journal: Molecular pharmaceutics 20120101
Title: Brentuximab vedotin and crizotinib in anaplastic large-cell lymphoma.
Journal: Cancer journal (Sudbury, Mass.) 20120101
Title: Glembatumumab vedotin, a conjugate of an anti-glycoprotein non-metastatic melanoma protein B mAb and monomethyl auristatin E for the treatment of melanoma and breast cancer.
Journal: Current opinion in molecular therapeutics 20100401
Title: EphA2 immunoconjugate as molecularly targeted chemotherapy for ovarian carcinoma.
Journal: Journal of the National Cancer Institute 20090902
Title: Potent antitumor activity of the anti-CD19 auristatin antibody drug conjugate hBU12-vcMMAE against rituximab-sensitive and -resistant lymphomas.
Journal: Blood 20090430
Title: Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index.
Journal: Nature biotechnology 20080801
Title: Combination of the anti-CD30-auristatin-E antibody-drug conjugate (SGN-35) with chemotherapy improves antitumour activity in Hodgkin lymphoma.
Journal: British journal of haematology 20080701
Title: Engineered antibody-drug conjugates with defined sites and stoichiometries of drug attachment.
Journal: Protein engineering, design & selection : PEDS 20060701
Title: Potent cytotoxicity of an auristatin-containing antibody-drug conjugate targeting melanoma cells expressing melanotransferrin/p97.
Journal: Molecular cancer therapeutics 20060601
Title: Lymphocyte activation antigen CD70 expressed by renal cell carcinoma is a potential therapeutic target for anti-CD70 antibody-drug conjugates.
Journal: Cancer research 20060215
Title: Evaluation of RGD-targeted albumin carriers for specific delivery of auristatin E to tumor blood vessels.
Journal: Bioconjugate chemistry 20060101
Title: Efficient elimination of B-lineage lymphomas by anti-CD20-auristatin conjugates.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20041201
Title: Okeley, et al. Intracellular Activation of SGN-35, a Potent Anti-CD30 Antibody-Drug Conjugate. Clinical Cancer Research (2010), 16(3), 888-897.
Title: Lisa Buckel, et al. Tumor radiosensitization by monomethyl auristatin E: mechanism of action and targeted delivery. Cancer Res. 2015 Apr 1;75(7):1376-87.
